Trial of blood glucose control and QOL change by sensor augmented pump (SAP) therapy and low glucose suspend (LGS)
Not Applicable
- Conditions
- Type 1 diabetes mellitus
- Registration Number
- JPRN-UMIN000037028
- Lead Sponsor
- Tokyo Women's Medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Undergoing hemodialysis Severe renal failure (eGFR less than 30 ml/min/1.73m2) Pregnant or potential patients Patients who the research director judged as inappropriate as subjects.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method